ABBV vs JNJ
ABBV 与 JNJ 的估值与基本面并排对比(公开数据)。
关键统计
| 指标 | ABBVAbbVie Inc. | JNJJohnson & Johnson |
|---|---|---|
| 市值 | $520.97B | $657.80B |
| 市盈率(TTM) | 83.3 | 41.5 |
| 市净率 | — | 8.07 |
| 市销率 | 8.5x | 7.0x |
| 股息率 | 2.24% | 1.88% |
| 营收 | $61.16B(TTM) | $99.33B(TTM) |
| 营收同比增长 | 8.6% | 6.0% |
| 净利润 | $6.31B(TTM) | $16.09B(TTM) |
| 净利同比增长 | -1.2% | 90.6% |
| 每股收益(稀释) | $3.54(TTM) | $6.58(TTM) |
| 息税前利润率 | 24.6% | 22.9% |
| 净资产收益率 | — | 32.9% |
| 投入资本回报率 | 18.6% | 16.3% |
| 皮氏F值 | — | 6/9 |
| 一年总回报 | +32.0% | +47.3% |
数据来自 SEC 文件 · 仅供参考 · 非投资建议
1 万美元的成长:ABBV vs JNJ
| 指标 | ABBV | JNJ |
|---|---|---|
| 期末价值 | $73.0K | $30.2K |
| 总回报 | +629.9% | +202.5% |
| 年化收益 (CAGR) | +21.2% | +11.3% |
| 波动率 | 25.8% | 18.8% |
| 夏普比率 | 0.72 | 0.44 |
| 索提诺比率 | 1.00 | 0.63 |
| 最大回撤 | -45.1% | -27.4% |
基于 2600 个共同交易日,2016-06-29 → 2026-10-30 · 无风险利率 4.16%(当前短端国债,全程恒定)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
相关对比
数据延迟 · 公开数据 · 仅供参考 · 非投资建议(本页不评判孰优孰劣)